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Background/aims: As hepatitis B and C virus have the same 
transmission routes, dual infection may occur. The aim of this 
study was to determine the seroprevalence of HCV in HBsAg-po­
sitive subjects. Methods: 139 HBsAg-positive subjects were en­
rolled in the study. Serum samples were tested using ELISA 
method for anti-HCV antibodies. Chi-square and Fisher's exact 
tests were used to compare the proportions. Results: There 
were 68 (48.9%) males and 71 (51.1%) females. The mean age 
was 41.89±11.30 years. One case was excluded because of ina­
dequate blood sampling. Anti-HCV antibody was positive in 17 
(12.3%) of the 138 remaining subjects. Seropositivity of HCV 
was similar between female and male patients (p=0.69). 
Conclusion: The seroprevalence of co-infection with hepatitis B 
virus and hepatitis C virus in our study was higher than such 
reports from some countries (Italy), but was in line with world­
wide prevalence (>10%). 
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INTRODUCTION 
Approximately 350 million people are infected 
with hepatitis B virus (HBV) worldwide (1). More 
than 3% of Iranian populations are infected with 
HBV (2). The seroprevalence of hepatitis C virus 
(HCV) in Iranian blood donors was reported as 
0.59% (3). As HBV and HCV have the same trans­
mission routes, dual infection may occur (4). Pati­
ents co-infected with both HBV and HCV may ha­
ve more severe liver disease and high mortality ra­
te (10%) (4). Therefore, it is very important to 
identify whether a patient with HBV infection is 
co-infected with HCV. 
Amaç: B ve C hepatitlerinin bulaﬂ yollar› ayn› oldu¤u için iki­
li enfeksiyonlar ortaya ç›kabilmektedir. Bu araﬂt›rman›n ama­
c›, HBsAg pozitif hastalarda HCV seropozitifli¤inin araﬂt›r›l­
mas›d›r. Yöntem: 139 HBsAg pozitif hasta çal›ﬂmaya al›nd›. 
Bu hastalar›n serum örnekleri anti-HCV pozitifli¤i aç›s›ndan 
ELISA yöntemi ile incelendi. Oranlar›n karﬂ›laﬂt›r›lmas› için 
Chi-kare ve Fisher’›n do¤rulama testleri kullan›ld›. Bulgular: 
68 (%48,9) erkek ve 71 (%51,1) kad›n hasta mevcuttu. Ortalama 
yaﬂ 41,89±11,30 y›ld›. Bir hasta yetersiz miktarda al›nan kan 
örne¤i nedeniyle çal›ﬂma d›ﬂ› b›rak›ld›. Geriye kalan 138 has­
talan›n 17’sinde (%12,3) anti-HCV pozitifli¤i tespit edildi. Ka­
d›n ve erkek hastalardaki seropozitiflik s›kl›¤› benzer bulundu. 
(p= 0,69) Sonuç: B ve C hepatitlerin birlikte enfekte hasta pre­
valans› benzer prevalans sonuçlar› veren ülkelerinkinden (‹tal­
ya) yüksektir ancak dünya genelindeki prevalansa (>%10) 
benzerdir. 
Anahtar kelimeler: B hepatiti, C hepatiti, ‹ran 
The present study was conducted to determine the 
seroprevalence of HCV in HBsAg-positive cases in 
Iran. 
MATERIALS AND METHODS 
During a population-based single stage cluster 
sampling in Golestan province of Iran (2004­
2005), 164 (8.9%) of 1850 cases were positive for 
HBsAg. One hundred and thirty-nine of these po­
sitive cases participated in the study. Anti-HCV 
antibody was detected using ELISA kit, DRG, 
Germany. Data were analyzed by SPSS v12. 
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Proportions were compared by chi-square and Fis­
her's exact tests. 
RESULTS 
Study participants included 68 (48.9%) males 
and 71 (51.1%) females. The mean age was 
41.89±11.30 years. Demographic characteristics of 
the subjects are summarized in Table 1. All of the 
participants were inactive carriers for HBV. One 
case was excluded because of inadequate blood 
sampling. Anti-HCV antibody was positive in 17 
(12.3%) of the 138 remaining subjects. Ten 
females (14.1%) and 7 males (10.4%) were positive 
Table 1. Demographic characteristics of HBsAg-posi­
tive cases in Golestan, Iran 
Variables Number of cases (%) 
Sex Male 68 (48.9) 
Female 71 (51.1) 
Age groups 25-34 44 (31.7) 
35-44 32 (23.0) 
45-54 40 (28.8) 
55-65 23 (16.5) 
Marital status Married 119 (85.6) 
Single 20 (14.4) 
Place of residence Rural 52 (38.10) 
Urban 86 (61.9) 
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for anti-HCV antibody (P = 0,69; Chi-Sq:0,153, 
CC: 0,033). The prevalence of HCV seropositivity 
was higher in the rural versus urban population, 
but the difference was not statistically significant. 
Seroprevalence of hepatitis C virus did not signifi­
cantly differ between age groups. 
DISCUSSION 
12.3% of the participants in the present study we­
re anti-HCV antibody-positive. HCV seropositivity 
among HBsAg-positive cases was reported as 2.7% 
by Barros et al. (5). Seroprevalence of HCV in the 
same population from Taiwan was 8% (6). In cont­
rast with these studies, de Miguel et al. (7) from 
Spain had detected anti-HCV antibody in 16% of 
HBV-infected subjects (higher prevalence rate 
than ours). 
In conformity with the previous reports, our re­
sults suggest that HCV is found in more than 10% 
of HBV-infected patients worldwide (4). In the 
present study, the seropositivity of HCV in 
females and males are similar, but Barros et al. (5) 
had reported a higher prevalence rate in males 
In conclusion, co-infection with HBV and HCV is 
common, especially in this area with its relatively 
high prevalence of hepatitis B. 
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